George:
As far as I know, this was an edict from the department of the
Interior,and not a law as such.
I think that you are beating a dead horse. Once Clifton found
out about this problem, they attempted to sell the ore to smelters
in Canada or Mexico, but in the meantime, the price of lead
dropped substantially: the combined drop of all three metals, gold-30yr low, silver-40% and lead over 50%, has currently put the Shear Veins on hold. But as prices return, which they will, the company will again bring the shear vein mining to the top
burner. Until then, the company will make money from the silver solutions and will also work on the Cane Springs. Again, I reiterate
that this company goal is survival in this vicious bear market in the metals, and imo will make it.
Initially, I was also skeptical of the American silver colloidal
silver project. I viewed it as a distraction from their main
mission, mining and selling silver, and gold ore.
However, a recent review of the colloidal silver project reveals
the following:
1) Clifton has a 40 % interest in American Silver.
2) Current estimates are that Clifton could
be making as much as $60,000.00 a week, by the end of the year (99) from its ownership position in American Silver alone, besides income from mining operations.
Analysis of just the expected American Silver revenues(not including
mining) show the potential to be very significant for Clifton shareholders: American Silver already has corporate buyers talking about needing 20,000-30,000 bottles a week-current production capacity is at about 13,000 bottles a week and American Silver has the ability to make the increase. The estimated weekly income is between $200,000-300,000, that would put Clifton's income at approximately $60,000/wk or $3,120,000/yr = earnings per share of about $0.1248 Even at current capacity earnings would be about half that number and that doesn't include any income from mining. Considering that
if they earn an annualized .06 per share, even a 10 multiple puts
the stock back at $.60 by the end of the 1999.
Apparently, the colloidal silver's medical antibacterial applications
have sparked a great deal of interest, and that is where the
demand appears to be the greatest. Their product is patented.
As with many if not most juniors, the main problem at Clifton
is absence of funding. They are working on financing that would
be minimally dilutive, with the purpose of developing the Cane
Springs gold project. In the meantime, it appears as if the
colloidal silver project will help keep the company afloat until
metal prices recover.
Regards
Dan |
